A theoretical approach for the acylation/deacylation mechanisms of avibactam in the reversible inhibition of KPC-2.

Ignacio Lizana, Elena A Uribe, Eduardo J Delgado

Journal: Journal of computer-aided molecular design 2022;35(9):943-952

PMID: 34236545

Abstract

Klebsiella pneumoniae carbapenemase (KPC-2) is the most commonly encountered class A β-lactamase variant worldwide, which confer high-level resistance to most available antibiotics. In this article we address the issue by a combined approach involving molecular dynamics simulations and hybrid quantum mechanics/molecular mechanics calculations. The study contributes to improve the understanding, at molecular level, of the acylation and deacylation stages of avibactam involved in the inhibition of KPC-2. The results show that both mechanisms, acylation and deacylation, the reaction occur via the formation of a tetrahedral intermediate. The formation of this intermediate corresponds to the rate limiting stage. The activation barriers are 19.5 kcal/mol and 23.0 kcal/mol for the acylation and deacylation stages, respectively. The associated rate constants calculated, using the Eyring equation, are 1.2 × 10 and 3.9 × 10 (s). These values allow estimating a value of 3.3 × 10 for the inhibition constant, in good agreement with the experimental value.

© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Address: Grupo QTC, Departamento de Físico-Química, Facultad de Ciencias Químicas, Universidad de Concepción, Concepción, Chile.; Millennium Nucleus on Catalytic Processes Towards Sustainable Chemistry, 4070386, Santiago, Chile.; Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.; Grupo QTC, Departamento de Físico-Química, Facultad de Ciencias Químicas, Universidad de Concepción, Concepción, Chile. [email protected].; Millennium Nucleus on Catalytic Processes Towards Sustainable Chemistry, 4070386, Santiago, Chile. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.